1021 Main Street Clinical Research Institute on Addictions Department of Pharmacology & Toxicology, Jacobs Schhol of Medicine and Biomedical Sciences, Universi Buffalo, New York 14203 Phone: (716) 881-7520 Fax: 716-881-7520 thanos@buffalo.edu
Research in my laboratory is focused upon distinct projects in the fields of Behavioral Neuropharmacology and Neuroimaging of Addiction and Substance Abuse. Our research is based on the notion that there are specific genetic and epigenetic vulnerabilities that significantly contribute to Reward Deficiency Syndrome (RDS) of which addiction is a part of. My lab utilizes molecular, behavioral, and imaging (Positron Emission Tomography, MRI, CT, Autoradiograpjy) methods in animal models as well as how these models contribute to clinical data as part of several ongoing clinical translational studies.
Education and Training:
Fellowship, Neuroscience and Neuroimaging of Drug Addiction, SUNY Stony Brook University (2000)
PhD, Biomedical Sciences / Neuroscience, Eastern Virginia Medical School / Old Dominion Unversity (1997)
MA, Biological Psychology, American University (1993)
BS, Psychology, Queen's University (1990)
Employment:
Senior Research Scientist, Department of Pharmacology & Toxicology, Jacobs School of Medicine and Biomedical Sciences, Department of Psychology, Clinical Research Institute on Addictions, University at Buffalo Jacobs School of Medicine & Biomedical Sciences
Awards and Honors:
Investigator Travel Award (2015)
Investigator Travel Award, RDS (2015)
Investigator Travel Award, Imaging of Alcoholism. NIAAA (2006)
US Department of Energy Science Mentor Award (2003)
PSA Investigator Scholarship Award (1996)
The Ralph D. Millard, M.D. Investigator Award. (1995)
PSA Investigator Scholarship Award (1994)
Massey Foundation Award
Research Expertise:
Behavioral Neuropharmacology and Neuroimaging of Addiction: Dr. Thanos’ current research includes five major areas: (1) human and animal models to study the underlying genetic and neural mechanisms of increased vulnerability to alcohol abuse after bariatric surgery; (2) determining the chronic effects of methylphenidate on skeletal development and brain function, behavior (3) dissection of the role of Fatty Acid Binding Proteins on endocannabinoid signaling and function on addiction. (4) Role of exercise on molecular markers of addiction and interaction with genetics. (5) Biomarkers of prenatal exposure to nicotine and cannabis.
Grants and Sponsored Research:
February 2022–August 2024 Prenatal Tobacco and Cannabis Exposure: A Translational Study NIH Role: Principal Investigator
October 2018–September 2023 Prenatal Tobacco and Cannabis Exposure: A Translational Study NIDA Role: Co-Principal Investigator $690,000
February 2022–January 2023 Response to cocaine following treatment with methylphenidate and fluoxetine. NIH Role: Co-Investigator $60,000
February 2022–February 2022 Iterative Learning and Automated Modular Platform for Optimum Nonaddictive Analgesic Discovery NCATS Role: Co-Investigator $50,000
February 2022–February 2022 Genetic and Psychosocial Risks of recidivism and alcohol abuse following bariatric surgery Blue Sky Role: Co-Principal Investigator $30,000
March 2018–March 2020 Fatty Acid Binding Protein - Mediated Control of Endocannabinoid Signaling and Drug Addiction NIDA Role: Co-Principal Investigator $250,000
September 2018–August 2019 Gastric Bypass, Brain Activity NY Research Foundation Role: Principal Investigator $30,000
February 2012–February 2019 Skeletal Effects of Methylphenidate NICHD Role: Co-Investigator $440,000
January 2016–January 2019 Increased Vulnerability to alcohol abuse after gastric bypass: Neural mechanisms NIAAA Role: Principal Investigator $250,000
June 2014–May 2018 Combined Cocaine and HIV Vaccine NIDA Role: Co-Investigator $163,300
July 2013–July 2015 The Dopamine Reward Circuit Activation Similarities between Food and Addiction SUNYProvost Role: Principal Investigator $264,000
Grady DL, Thanos PK, Corrada MM, Barnett JC, Ciobanu V, Shustarovich D, Napoli A, Moyzis AG, Grandy D, Rubinstein M, Wang GJ, Kawas CH, Chen C, Dong Q, Wang E, Volkow ND, Moyzis RK. (2013) DRD4 genotype predicts longevity in mouse and human. The Journal of neuroscience : the official journal of the Society for Neuroscience (Jan), 33(1): 286-91. doi:10.1523/JNEUROSCI.3515-12.2013
Wang GJ, Volkow ND, Franceschi D, Fowler JS, Thanos PK, Scherbaum N, Pappas N, Wong CT, Hitzemann RJ, Felder CA. (2000) Regional brain metabolism during alcohol intoxication. Alcoholism, clinical and experimental research (Jun), 24(6): 822-9.
International Society of Reward Deficiency; member (2015–2019)
Research Society on Alcoholism; Member (1999–present)
Society for Neuroscience; Member (1995–present)
Service Activities:
Participated in annual conference with presentation and meet with students; Assisted with planning meetings and faculty member of the Ingestive Behavior Center at UB (2022)
faculty member, will assist with future conference; faculty member of the UB CeCaR. (2022)
Poster reviewer for annual conference of CSTEP since 2017; Poster Reviewer (2022)
Assisted with Poster review on research day of CRIA, 2016-2020; Poster reviewer (2022)
Will review and delegate reviews on papers in the area of psychopharmacology; Section Editor, Current Pharmaceutical Design (2021–2022)
Reviewer of manuscripts in my area of expertise; member of the Editorial Board Journal of Precision Medicine (2021–2022)
Section editor for Behavioral Pharmacology in the journal Current Psychopharmacology; Section Editor (2020–2022)
1021 Main Street Clinical Research Institute on Addictions Department of Pharmacology & Toxicology, Jacobs Schhol of Medicine and Biomedical Sciences, Universi Buffalo, New York 14203 Phone: (716) 881-7520 Fax: 716-881-7520 thanos@buffalo.edu